Tech Company Financing Transactions

Remedium Bio Funding Round

Sherwood Ventures, Angel Star Ventures and Apis Health Angels participated in a $2.3 million Seed capital raise for Remedium Bio. This VC investment round was announced on 8/16/2022.

Transaction Overview

Company Name
Announced On
8/16/2022
Transaction Type
Venture Equity
Amount
$2,300,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to study its lead product, a single-injection gene therapy potentially capable of reversing cartilage loss, in a collaboration with Tufts University School of Medicine scientists researching rheumatic disorders.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1116 Great Plain Ave 203
Needham, MA 02492
USA
Email Address
Overview
Remedium Bio is a Boston based gene therapy company focused on the development of highly innovative treatments for a broad range of diseases. The Remedium approach utilizes proven scientific fundamentals, in a novel way, to treat the most debilitating conditions. Starting with well-characterized pathophysiological principles, our scientists modularly apply proven technologies to quickly advance curative treatments through the R&D cycle. Today, our leading candidates include gene therapy treatments in the fields of Endocrinology, Cardiology, Hematology, and Rheumatology.
Profile
Remedium Bio LinkedIn Company Profile
Social Media
Remedium Bio Company Twitter Account
Company News
Remedium Bio News
Facebook
Remedium Bio on Facebook
YouTube
Remedium Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Francesco Luppino
  Francesco Luppino LinkedIn Profile  Francesco Luppino Twitter Account  Francesco Luppino News  Francesco Luppino on Facebook
Chief Operating Officer
Alex Goraltchouk
  Alex Goraltchouk LinkedIn Profile  Alex Goraltchouk Twitter Account  Alex Goraltchouk News  Alex Goraltchouk on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/16/2022: Sync Computing venture capital transaction
Next: 8/16/2022: GrowthSpace venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary